Capivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 (HealthDay News) — For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longe…
Learn MoreCapivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 (HealthDay News) — For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longe…
Learn MoreHigher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
MONDAY, June 5, 2023 (HealthDay News) — For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an exce…
Learn MoreHigher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
MONDAY, June 5, 2023 (HealthDay News) — For patients with stroke of recent onset or progression of stroke symptoms and no occlusion of large or medium-sized cerebral vessels, intravenous tirofiban is associated with an increased likelihood of an exce…
Learn MoreSubclinical CVD Linked to Increased Risk for Mortality in Diabetes
MONDAY, June 5, 2023 (HealthDay News) — For adults with diabetes, subclinical cardiovascular disease (CVD), as assessed by cardiac biomarkers, is associated with an increased risk for all-cause and CVD mortality, according to a study published online…
Learn MoreSubclinical CVD Linked to Increased Risk for Mortality in Diabetes
MONDAY, June 5, 2023 (HealthDay News) — For adults with diabetes, subclinical cardiovascular disease (CVD), as assessed by cardiac biomarkers, is associated with an increased risk for all-cause and CVD mortality, according to a study published online…
Learn MoreGlycemic Control Improved With Exercise in the Afternoon
MONDAY, June 5, 2023 (HealthDay News) — For adults with overweight or obesity and type 2 diabetes, bout-related moderate-to-vigorous physical activity (bMVPA) performed in the afternoon is associated with improvements in glycemic control, according t…
Learn MoreGlycemic Control Improved With Exercise in the Afternoon
MONDAY, June 5, 2023 (HealthDay News) — For adults with overweight or obesity and type 2 diabetes, bout-related moderate-to-vigorous physical activity (bMVPA) performed in the afternoon is associated with improvements in glycemic control, according t…
Learn MoreTranscatheter Mitral Valve Repair Safe for Mitral Regurgitation
MONDAY, June 5, 2023 (HealthDay News) — For patients with degenerative mitral regurgitation (MR), transcatheter edge-to-edge mitral valve repair is safe and has a high rate of success, according to a study published in the May 23/30 issue of the Jour…
Learn MoreTranscatheter Mitral Valve Repair Safe for Mitral Regurgitation
MONDAY, June 5, 2023 (HealthDay News) — For patients with degenerative mitral regurgitation (MR), transcatheter edge-to-edge mitral valve repair is safe and has a high rate of success, according to a study published in the May 23/30 issue of the Jour…
Learn More